TransMedics Down Over 25%, On Track for Largest Percent Decrease Since October 2024 -- Data Talk

Dow Jones05-07

TransMedics Group, Inc. $(TMDX)$ is currently at $70.77, down $24.16 or 25.45%

 

--Would be lowest close since April 8, 2025, when it closed at $67.95

--On pace for largest percent decrease since Oct. 29, 2024, when it fell 29.9%

--Currently down nine of the past 10 days

--Currently down four consecutive days; down 29.78% over this period

--Longest losing streak since April 29, 2026, when it fell for five straight trading days

--Worst four day stretch since the four days ending Nov. 1, 2024, when it fell 34.73%

--Down 41.82% year-to-date

--Down 59.81% from its all-time closing high of $176.11 on Aug. 27, 2024

--Down 26.13% from 52 weeks ago (May 7, 2025), when it closed at $95.81

--Down 52.95% from its 52-week closing high of $150.42 on Dec. 1, 2025

--Would be a new 52-week closing low

--Traded as low as $70.35; lowest intraday level since April 9, 2025, when it hit $66.85

--Down 25.89% at today's intraday low; largest intraday percent decrease since Oct. 29, 2024, when it fell as much as 32.27%

 

All data as of 2:47:01 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 06, 2026 14:49 ET (18:49 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment